Myrobalan Therapeutics
PrivateLast Round
Grant
Mar 13, 2025
Total Funding Raised
$54.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Myrobalan Therapeutics is a biotechnology company that develops oral neurorestorative therapies designed to reverse the underlying pathologies of brain dysfunctions and central nervous system conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myrobalan Therapeutics Comparables
Compare Myrobalan Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pheno Therapeutics | 89% | |
| Progentos Therapeutics | 85% | |
| Convelo Therapeutics | 83% | |
Myrobalan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 13, 2025 | ||||
| Grant | Feb 7, 2024 | ||||
| Series A | Jan 10, 2024 | ||||
| Seed | Apr 1, 2022 | ||||
| Seed | Sep 1, 2021 |
Myrobalan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Bencao Capital | Series A, Seed |
| Co-Win Ventures | Series A |
| National MS Society | Grant |
| Ab Magnitude Ventures Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 70% MoM, reaching 4.1K.
- Jun 20, 2026
Monthly visitors increased 63% MoM.
Myrobalan Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myrobalan Therapeutics's valuation, stock price, and market status.